Hover a dot or row, or tab through the dots · bars scaled to the largest round ($226M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-386253
First filed2021-01-13
Latest2021-01-13
Sought$226M
Sold$226M
Investors27
Exemptions506(b)
021-302491
First filed2018-01-05
Latest2018-01-05
Sought$7M
Sold$7M
Investors5
Exemptions506(b)
Who backs Affinivax, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2021-01-13
Related persons
Name
Relationship
Steven Brugger
RelationshipExecutive Officer, Director
Steven Altschuler
RelationshipDirector
Andrew Hack
RelationshipDirector
Frances Heller
RelationshipDirector
Richard Malley
RelationshipDirector
Robert More
RelationshipDirector
George Siber
RelationshipDirector
Facts
As its latest Form D states them
Industry
Biotechnology
State
Massachusetts (MA)
Exemptions
Rule 506(b)
First filed
2018-01-05
Latest filing
2021-01-13
Who backs Affinivax, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)